Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Cheng Sohanya Roshan
EVP & Chief Commercial Officer at Karyopharm Therapeutics. Filing since 13 Jun 2022.
CIK 0001865796
Company
Date
Role
Action
Shares
Amount
Of holding
KPTI
Karyopharm Therapeutics Inc.
14 May 2026
EVP & Chief Commercial Officer
Sold at will
324
$3.08K
0.3%
KPTI
Karyopharm Therapeutics Inc.
2 Mar 2026
EVP & Chief Commercial Officer
Sold at will
4,604
$43.32K
4.1%
KPTI
Karyopharm Therapeutics Inc.
15 Sep 2025
EVP & Chief Commercial Officer
Sold at will
325
$2.09K
0.9%
KPTI
Karyopharm Therapeutics Inc.
4 Mar 2025
EVP & Chief Commercial Officer
Sold at will
3,445
$21.67K
9.1%
KPTI
Karyopharm Therapeutics Inc.
4 Sep 2024
EVP & Chief Commercial Officer
Sold at will
5,356
$3.87K
1.3%
KPTI
Karyopharm Therapeutics Inc.
1 Mar 2024
EVP & Chief Commercial Officer
Sold at will
5,109
$6.13K
1.3%
KPTI
Karyopharm Therapeutics Inc.
29 Feb 2024
EVP & Chief Commercial Officer
Sold at will
21,840
$25.55K
5.2%
KPTI
Karyopharm Therapeutics Inc.
1 Sep 2023
EVP & Chief Commercial Officer
Sold at will
7,415
$9.87K
3.5%
KPTI
Karyopharm Therapeutics Inc.
8 Jun 2023
EVP & Chief Commercial Officer
Sold on a plan
1,839
$4.32K
0.9%
KPTI
Karyopharm Therapeutics Inc.
1 Mar 2023
EVP & Chief Commercial Officer
Sold, plan not stated
11,239
$34.05K
5.1%
KPTI
Karyopharm Therapeutics Inc.
13 Jun 2022
Chief Commercial Officer
Sold, plan not stated
1,551
$8.07K
1.7%
11 decisions on file.
